Immunoglobulins or a transfusion: what should you report before a live vaccine?

Before a proposed live vaccine, mention any immunoglobulins or transfusion you have received. Some products supply ready-made antibodies. These may reduce the response to a live vaccine, including measles or chickenpox vaccination; the issue then concerns effectiveness and timing.

This mechanism differs from the risks of a live vaccine in someone with immune suppression. It also does not mean that every vaccine or blood product follows the same rules. The professional needs to identify the exact vaccine and the products you received.

Gather infusion, transfusion or hospital-discharge records showing the administered product and date. Add records of recent vaccinations. If information is missing, ask the team that treated you how to retrieve it for the check, rather than filling the gap with an assumption.

The intervals described in the sources vary with the vaccine, the product and the amount of immunoglobulins received. The professional refers to the leaflet or characteristics of the vaccine concerned. Do not calculate a date yourself using an interval found for another product: such information does not give you personal clearance for vaccination.

The order also matters in the other direction. Some products containing antibodies can reduce the response to a chickenpox vaccine when given afterwards. Report a recent vaccine if an infusion or blood product is being considered. Do not delay care considered essential on your own initiative; have the relevant teams coordinate their decisions.

For a planned procedure, show the records to the professionals overseeing treatment and to the person organising vaccination. Ask who checks the interactions and confirms appropriate timing. After recent contact with chickenpox, follow the medical instructions specific to that exposure without waiting to complete the records.